Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroids for Obstructive Jaundice in AIP/IgG4-SC
NCT02797665Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2016
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of prednisone in autoimmune pancreatitis (AIP) and IgG4-related sclerosing cholangitis (IgG4-SC) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Clinical remission rate of obstructive jaundice at Day 60. Status: unknown.
02
Drugs
prednisone
03
Conditions
autoimmune pancreatitis (AIP)IgG4-related sclerosing cholangitis (IgG4-SC)
Beyond the preview
Go deeper on NCT02797665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02797665.